Reed Beall

University of Calgary

University Drive

Calgary, T2N 1N4

Canada

  • University of Calgary

SCHOLARLY PAPERS

3

DOWNLOADS

54

TOTAL CITATIONS

0

Scholarly Papers (3)

Actions:
Email selected abstracts
1.

Patents and Regulatory Exclusivities on FDA Approved Insulin Products: A Longitudinal Database Study, 1986-2019

PLOS Medicine, volume 20, issue 11, 2023[10.1371/journal.pmed.1004309], WVU College of Law Research Paper, No. 2024-027
Number of pages: 20 Posted: 17 Sep 2024 Last Revised: 17 Dec 2024
T. Anders Olson, Reed Beall, Ryan Knox, S. Sean Tu, Aaron S. Kesselheim and William Feldman
Program On Regulation, Therapeutics, And Law (PORTAL), Brigham and Women's Hospital and Harvard Medical School, University of Calgary, Harvard-MIT Center for Regulatory Science, West Virginia University College of Law, Brigham and Women's Hospital/Harvard Medical School and Harvard University - Harvard Medical School
Downloads 54 (821,743)

Abstract:

Loading...

pharmaceutical patents, patent law, insulin, diabetes, regulatory exclusivities, market exclusivity

2.

Patent Challenges and Litigation on Inhalers for Asthma and Copd

WVU College of Law Research Paper No. 2024-028, Health Affairs, volume 42, issue 3, 2023[10.1377/hlthaff.2022.00873]
Posted: 17 Sep 2024
Sanjay Reddy, Reed Beall, S. Sean Tu, Aaron S. Kesselheim and William Feldman
Georgetown University, University of Calgary, West Virginia University College of Law, Brigham and Women's Hospital/Harvard Medical School and Harvard University - Harvard Medical School

Abstract:

Loading...

patent law, pharmaceutical patents, asthma, inhalers, COPD, FDA, generic drugs, market exclusivity, Hatch-Waxman Act

3.

Patents and Regulatory Exclusivities on Glp-1 Receptor Agonists

WVU College of Law Research Paper No. 2024-019, JAMA, Vol. 330(7), p. 650-657 (2023)
Posted: 26 Aug 2024
Rasha Alhiary, Aaron S. Kesselheim, Sarah Gabriele, Reed Beall, S. Sean Tu and William Feldman
Program On Regulation, Therapeutics, And Law (PORTAL), Brigham and Women's Hospital and Harvard Medical School, Brigham and Women's Hospital/Harvard Medical School, Program On Regulation, Therapeutics, And Law (PORTAL), Brigham and Women's Hospital and Harvard Medical School, University of Calgary, West Virginia University College of Law and Harvard University - Harvard Medical School

Abstract:

Loading...

GPL-1 receptor agonists, patent law, drug patents, pharmaceutical patents, FDA